We are live on ! Find out more
Point72 Asset Management

Point72 Asset Management Portfolio holdings

AUM $78.1B
1-Year Est. Return 55.25%
This Fund
S&P 500
This Quarter Est. Return
+34.87%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$15.3B
AUM Growth
+$3.02B
Cap. Flow
+$216M
Cap. Flow %
1.41%
Top 10 Hldgs %
15.76%
Holding
1,113
New
368
Increased
189
Reduced
211
Closed
335

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$284M
2
FISV
Fiserv Inc
FISV
+$232M
3
BABA icon
Alibaba
BABA
+$183M
4
CXO
CONCHO RESOURCES INC.
CXO
+$123M
5
ORCL icon
Oracle
ORCL
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 21.51%
2 Technology 20.2%
3 Consumer Discretionary 14.79%
4 Financials 9.67%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UFS
376
CALL
DELISTED
DOMTAR CORPORATION (New)
UFS
$8.44M 0.06%
+400,000
New +$8.68M
PLMR icon
377
Palomar
PLMR
$3.55B
$8.33M 0.05%
+97,163
New +$6.45M
FTS icon
378
Fortis
FTS
$29B
$8.32M 0.05%
219,000
+27,000
+14% +$1.03M
SMPL icon
379
Simply Good Foods
SMPL
$901M
$8.27M 0.05%
445,342
-410,304
-48% -$7.27M
XENE icon
380
Xenon Pharmaceuticals
XENE
$6.06B
$8.27M 0.05%
659,404
+74,351
+13% +$946K
APLT
381
DELISTED
Applied Therapeutics
APLT
$8.27M 0.05%
228,724
-300,750
-57% -$12.6M
IOVA icon
382
CALL
Iovance Biotherapeutics
IOVA
$1.82B
$8.23M 0.05%
300,000
-60,000
-17% -$1.97M
ELAN icon
383
Elanco Animal Health
ELAN
$13.2B
$8.2M 0.05%
382,366
-712,022
-65% -$15.7M
NGNE icon
384
Neurogene
NGNE
$656M
$8.15M 0.05%
24,550
-5,510
-18% -$1.44M
BURL icon
385
Burlington
BURL
$23.2B
$8.14M 0.05%
41,342
-84,358
-67% -$15.9M
ROKU icon
386
Roku
ROKU
$21.5B
$8.05M 0.05%
+69,118
New +$7.91M
ALL icon
387
Allstate
ALL
$68B
$7.9M 0.05%
81,471
-706,702
-90% -$69.4M
ATI icon
388
ATI
ATI
$25.6B
$7.89M 0.05%
+774,327
New +$6.71M
ODFL icon
389
Old Dominion Freight Line
ODFL
$44.1B
$7.88M 0.05%
92,952
+81,652
+723% +$6.2M
TVTX icon
390
Travere Therapeutics
TVTX
$5.2B
$7.88M 0.05%
386,126
+82,746
+27% +$1.32M
OMF icon
391
OneMain Financial
OMF
$7.2B
$7.8M 0.05%
317,850
-678,641
-68% -$15.5M
NYT icon
392
New York Times
NYT
$12.1B
$7.79M 0.05%
+185,262
New +$6.74M
CYTK icon
393
Cytokinetics
CYTK
$10.5B
$7.74M 0.05%
328,277
-462,923
-59% -$8.68M
AMRN
394
Amarin Corp
AMRN
$299M
$7.67M 0.05%
55,432
-405,418
-88% -$55.8M
AIG icon
395
American International
AIG
$41.7B
$7.61M 0.05%
+244,103
New +$6.85M
RRC icon
396
Range Resources
RRC
$9.38B
$7.59M 0.05%
+1,348,536
New +$7.48M
JCI icon
397
Johnson Controls International
JCI
$88.8B
$7.57M 0.05%
221,729
-1,021,204
-82% -$31.4M
COHR icon
398
Coherent
COHR
$51.4B
$7.57M 0.05%
+160,240
New +$6.35M
CRI icon
399
Carter's
CRI
$1.42B
$7.56M 0.05%
+93,671
New +$7.46M
CVLT icon
400
Commault Systems
CVLT
$4.88B
$7.54M 0.05%
194,706
+173,706
+827% +$6.89M

Similar funds

Point72 Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Point72 Asset Management held 1,113 positions worth $15.3B, up 25% from $12.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Point72 Asset Management's Q2 2020 filing shows 368 new, 189 increased, 211 reduced and 335 closed positions. Its largest new stake was Merck: 3,769,218 shares worth $278M. The largest sale was Micron Technology, an estimated $287M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Point72 Asset Management's largest Q2 2020 buy was Merck: 3,769,218 shares worth $278M.
  • Point72 Asset Management added most to Fiserv Inc in Q2 2020, an estimated $232M increase.
  • Point72 Asset Management's biggest Q2 2020 reduction was Micron Technology, cutting an estimated $287M.
  • Point72 Asset Management fully exited CSX Corp in Q2 2020, selling an estimated $110M.
  • Point72 Asset Management's ten largest holdings make up 16% of its $15.3B portfolio in Q2 2020.
  • Point72 Asset Management opened 368 new positions and closed 335 in Q2 2020.
  • Point72 Asset Management's portfolio value rose 25% quarter-over-quarter to $15.3B.

Based on Point72 Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.